Common variable immunodeficiency
A primary immunodeficiency disorder
| Common variable immunodeficiency | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | CVID, Acquired hypogammaglobulinemia |
| Pronounce | N/A |
| Field | Immunology |
| Symptoms | Recurrent respiratory and gastrointestinal infections, fatigue, autoimmune disorders, enlarged lymph nodes, splenomegaly |
| Complications | Chronic lung disease, lymphoma, autoimmune diseases, gastrointestinal inflammation |
| Onset | Usually in late childhood or early adulthood (ages 20–40) |
| Duration | Lifelong |
| Types | Varies depending on severity and complications |
| Causes | Mostly unknown; associated with genetic mutations in some cases (e.g., TNFRSF13B, ICOS) |
| Risks | Family history of immunodeficiency, autoimmune disorders |
| Diagnosis | Low levels of immunoglobulins (especially IgG, IgA, and/or IgM), poor response to vaccines, clinical symptoms |
| Differential diagnosis | X-linked agammaglobulinemia, Selective IgA deficiency, Hyper IgM syndrome |
| Prevention | None |
| Treatment | Immunoglobulin replacement therapy (IVIG or SCIG), treatment of infections, immunosuppressants for autoimmune complications |
| Medication | Immunoglobulin therapy, antibiotics, corticosteroids, immunomodulators |
| Prognosis | Variable; improved with treatment, but increased risk of complications |
| Frequency | Estimated at 1 in 25,000 to 1 in 50,000 people |
| Deaths | Related to complications if untreated or misdiagnosed |
Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by low levels of serum immunoglobulins and an increased susceptibility to infections. It is one of the most frequently diagnosed primary immunodeficiencies and can present at any age, although it is most commonly diagnosed in adults.
Pathophysiology[edit | edit source]
CVID is a heterogeneous disorder with a complex pathophysiology. It involves defects in the B cell differentiation process, leading to impaired production of immunoglobulins (antibodies). This results in decreased levels of IgG, IgA, and sometimes IgM. The exact genetic causes of CVID are not fully understood, but mutations in several genes, including TNFRSF13B (TACI), have been implicated.
Clinical Features[edit | edit source]
Patients with CVID typically present with recurrent infections, particularly of the respiratory tract, such as sinusitis, bronchitis, and pneumonia. They may also experience gastrointestinal infections and chronic diarrhea. In addition to infections, individuals with CVID are at increased risk for autoimmune disorders, granulomatous disease, and certain types of cancer, particularly lymphoma.
Diagnosis[edit | edit source]
The diagnosis of CVID is based on clinical presentation and laboratory findings. Key diagnostic criteria include:
- Low levels of serum IgG, IgA, and/or IgM
- Poor response to vaccines
- Exclusion of other causes of hypogammaglobulinemia
Additional tests may include assessment of B cell numbers and function, as well as genetic testing to identify potential mutations associated with the disorder.
Treatment[edit | edit source]
The mainstay of treatment for CVID is immunoglobulin replacement therapy, which helps to reduce the frequency and severity of infections. This can be administered intravenously (IVIG) or subcutaneously (SCIG). In addition to immunoglobulin therapy, patients may require antibiotics to treat or prevent infections. Management of associated autoimmune or inflammatory conditions may involve the use of immunosuppressive medications.
Prognosis[edit | edit source]
The prognosis for individuals with CVID varies depending on the severity of the condition and the presence of complications. With appropriate treatment, many patients can lead relatively normal lives, although they may still experience recurrent infections and other health issues.
Related pages[edit | edit source]
External links[edit | edit source]
| Classification | |
|---|---|
| External resources |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
